Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
3 "Awareness"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Guideline/Fact Sheet
Article image
Diabetes Mellitus in the Elderly Adults in Korea: Based on Data from the Korea National Health and Nutrition Examination Survey 2019 to 2020
Seung-Hyun Ko, Kyung Do Han, Yong-Moon Park, Jae-Seung Yun, Kyuho Kim, Jae-Hyun Bae, Hyuk-Sang Kwon, Nan-Hee Kim
Diabetes Metab J. 2023;47(5):643-652.   Published online August 7, 2023
DOI: https://doi.org/10.4093/dmj.2023.0041
  • 3,695 View
  • 263 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We evaluated the prevalence and management of diabetes mellitus (DM) in elderly Korean patients based on data from the Korea National Health and Nutrition Examination Survey (KNHANES).
Methods
A total of 3,068 adults aged 65 years and older (19.8% of total population) were analyzed using KNHANES from 2019 to 2020. Prevalence, awareness, treatment, and control rates, and comorbidities were analyzed. Lifestyle behaviors and energy intake were also measured.
Results
The prevalence of DM and prediabetes was 29.6% and 50.5%, respectively. The awareness, treatment and control rates were 76.4%, 73.3%, and 28.3%, respectively. The control rate was 77.0% if A1C <7.5% criteria was used. The mean A1C value of individuals with known DM was 7.1%, and 14.5% of the known DM patients had A1C ≥8.0%. Abdominal obesity, hypertension, and hypercholesterolemia were combined with DM in 63.9%, 71.7%, and 70.7%, respectively, and the rate of integrated management was 36.0% (A1C <7.5% criteria). A total of 40.1% of those with DM walked regularly. The percentage of energy intake from carbohydrates was higher in those with DM than in those without DM (P=0.044), while those of fat (P=0.003) and protein (P=0.025) were lower in those with DM than in those without DM in women.
Conclusion
In 2019 to 2020, three of 10 adults aged 65 years and older in Korea had DM, and approximately 70% of them had comorbidities. A strategy for more individualized comprehensive care for the elderly patients with DM is urgently needed.

Citations

Citations to this article as recorded by  
  • Association Between High Blood Folate Levels and Glaucoma in a Representative Korean Population
    Ji Young Lee, Jin A. Choi, Sung Pyo Park, Donghyun Jee
    Investigative Opthalmology & Visual Science.2024; 65(1): 6.     CrossRef
  • Is the change in longitudinal cognitive function in older adults with diabetes affected by trajectory classes of depressive symptoms?
    Gyeong A Kang, Ju Young Yoon
    Public Health Nursing.2024; 41(5): 1006.     CrossRef
  • Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients
    Jae-Seung Yun, Kyuho Kim, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2024; 48(4): 531.     CrossRef
  • The Growing Challenge of Diabetes Management in an Aging Society
    Seung-Hwan Lee
    Diabetes & Metabolism Journal.2023; 47(5): 630.     CrossRef
Metabolic Risk/Epidemiology
Article image
Importance of Awareness and Treatment for Diabetes in Influenza Vaccination Coverage of Diabetic Patients under 65 Years: A Population-Based Study
Yu Mi Ko, Seung Hyun Ko, Kyoungdo Han, Yong-Moon Park, Joon Young Choi, Shin Young Kim, So Hyang Song, Chi Hong Kim, Sung Kyoung Kim
Diabetes Metab J. 2021;45(1):55-66.   Published online May 29, 2020
DOI: https://doi.org/10.4093/dmj.2019.0189
  • 7,857 View
  • 142 Download
  • 8 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Influenza is a global public health problem causing considerable morbidity and mortality. Although vaccination is the most effective way to prevent infection, vaccination coverage is insufficient in people with chronic disease under 65 years, especially diabetes. The purpose of this study was to evaluate influenza vaccination coverage and identify factors associated with influenza vaccination in Korean diabetic adults under 65 years.

Methods

Data were obtained from 24,821 subjects in the Korea National Health and Nutrition Examination Survey (2014 to 2017). Socioeconomic, health-related, and diabetic factors were investigated for their relations with influenza vaccination in diabetic patients under 65 years using univariate and multivariate analyses.

Results

Among 24,821 subjects, 1,185 were diabetic patients under 65 years and their influenza vaccination rate was 36.5%. Socioeconomic (older age, female gender, non-smoker, light alcohol drinker, lower educational level, and employed status), health-related factors (lower fasting glucose and glycosylated hemoglobin level, good self-perceived health status, more comorbidities, recent health screening, more outpatient visits, and diet therapy), and diabetic factors (more awareness and getting treated) were associated with influenza vaccination. In multivariate analysis, more awareness and getting treated for diabetes were associated with influenza vaccination in diabetic patients under 65 years (odds ratio, 1.496 and 1.413; 95% confidence interval, 1.022 to 2.188 and 1.018 to 2.054, respectively).

Conclusion

Influenza vaccination rate was low in diabetic patients under 65 years, especially in those with unawareness and not getting treated for diabetes. Active screening and treatment for diabetes may be helpful to improve the influenza vaccination rate in these patients.

Citations

Citations to this article as recorded by  
  • Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population‐based study
    Xiangju Hu, Xin Fang, Minxia Wu
    Journal of Diabetes Investigation.2024; 15(8): 1034.     CrossRef
  • Adherence to Advisory Committee on Immunization Practices in diabetes mellitus patients in Saudi Arabia: A multicenter retrospective study
    Saleh Fahad Alqifari, Aya K Esmail, Dalal M Alarifi, Ghalya Y Alsuliman, Maram M Alhati, May R Mutlaq, Mohammed Aldhaeefi, Shaden A Alshuaibi, Palanisamy Amirthalingam, Abrar Abdallah, Afaf S Wasel, Heba R Hamad, Shoroq Alamin, Tasneem H Atia, Tariq Alqah
    World Journal of Diabetes.2024; 15(3): 440.     CrossRef
  • ЕГДЕ ЖАСТАҒЫ АДАМДАРДА COVID-19 ВАКЦИНАЦИЯСЫНЫҢ ТИІМДІЛІГІ
    Ю.Р. АБДУСАТТАРОВА, Д.С. ӘБЕН, Н. АБДОЛЛА, Р.Т. ТЛЕУЛИЕВА, А. КАЛИ, Ю.В. ПЕРФИЛЬЕВА
    Vestnik.2023; (2(65)): 48.     CrossRef
  • Comorbidities associated with high-risk obstructive sleep apnea based on the STOP-BANG questionnaire: a nationwide population-based study
    Gene Huh, Kyoung do Han, Yong-Moon Park, Chan-Soon Park, Kyu-na Lee, Eun Young Lee, Jung-Hae Cho
    The Korean Journal of Internal Medicine.2023; 38(1): 80.     CrossRef
  • Influenza vaccination trend and related factors among patients with diabetes in Korea: Analysis using a nationwide database
    Dong-Hwa Lee, Bumhee Yang, Seonhye Gu, Eung-Gook Kim, Youlim Kim, Hyung Koo Kang, Yeong Hun Choe, Hyun Jeong Jeon, Seungyong Park, Hyun Lee
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Factors associated with seasonal influenza immunization in people with chronic diseases
    Slađana Arsenović, Tatjana Gazibara
    Medicinski podmladak.2021; 72(2): 19.     CrossRef
Review
Clinical Diabetes & Therapeutics
Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
Ahmed Iqbal, Peter Novodvorsky, Simon R. Heller
Diabetes Metab J. 2018;42(1):3-18.   Published online February 23, 2018
DOI: https://doi.org/10.4093/dmj.2018.42.1.3
  • 7,560 View
  • 96 Download
  • 19 Web of Science
  • 20 Crossref
AbstractAbstract PDFPubReader   

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune condition that requires life-long administration of insulin. Optimal management of T1DM entails a good knowledge and understanding of this condition both by the physician and the patient. Recent introduction of novel insulin preparations, technological advances in insulin delivery and glucose monitoring, such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring and improved understanding of the detrimental effects of hypoglycaemia and hyperglycaemia offer new opportunities and perspectives in T1DM management. Evidence from clinical trials suggests an important role of structured patient education. Our efforts should be aimed at improved metabolic control with concomitant reduction of hypoglycaemia. Despite recent advances, these goals are not easy to achieve and can put significant pressure on people with T1DM. The approach of physicians should therefore be maximally supportive. In this review, we provide an overview of the recent advances in T1DM management focusing on novel insulin preparations, ways of insulin administration and glucose monitoring and the role of metformin or sodium-glucose co-transporter 2 inhibitors in T1DM management. We then discuss our current understanding of the effects of hypoglycaemia on human body and strategies aimed at mitigating the risks associated with hypoglycaemia.

Citations

Citations to this article as recorded by  
  • Health-Related Quality of Life of Adolescents and Children With Type 1 Diabetes in the Jazan Region of Saudi Arabia
    Gassem A Gohal, Aqilah Majhali, Esaam Moafa, Sarah H Talebi, Bushra I Maashi, Amani Mutaen, Walaa J Alhamdan, Ibrahim M Dighriri
    Cureus.2024;[Epub]     CrossRef
  • An automatic deep reinforcement learning bolus calculator for automated insulin delivery systems
    Sayyar Ahmad, Aleix Beneyto, Taiyu Zhu, Ivan Contreras, Pantelis Georgiou, Josep Vehi
    Scientific Reports.2024;[Epub]     CrossRef
  • Nose-to-brain delivery of insulin nanoparticles for diabetes management: A review
    Manoj Kumbhare, Ajaykumar Surana, Pravin Morankar
    Baghdad Journal of Biochemistry and Applied Biological Sciences.2023; 4(02): 39.     CrossRef
  • Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study
    Sejeong Lee, KyungYi Kim, Ji Eun Kim, Yura Hyun, Minyoung Lee, Myung-Il Hahm, Sang Gyu Lee, Eun Seok Kang
    Diabetes & Metabolism Journal.2023; 47(5): 693.     CrossRef
  • Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
    Ingrid Wijk, Susanne Amsberg, Unn-Britt Johansson, Fredrik Livheim, Eva Toft, Therese Anderbro
    BMJ Open.2023; 13(12): e072061.     CrossRef
  • Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic β-cells
    Ye-Jee Lee, Esder Lee, Young-Hye You, Yu-Bae Ahn, Ki-Ho Song, Ji-Won Kim, Seung-Hyun Ko
    Journal of Drug Targeting.2021; 29(1): 88.     CrossRef
  • Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
    Jong Ha Baek, Woo Je Lee, Byung-Wan Lee, Soo Kyoung Kim, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2021; 45(1): 46.     CrossRef
  • The impact of chemical engineering and technological advances on managing diabetes: present and future concepts
    Sabine Szunerits, Sorin Melinte, Alexandre Barras, Quentin Pagneux, Anna Voronova, Amar Abderrahmani, Rabah Boukherroub
    Chemical Society Reviews.2021; 50(3): 2102.     CrossRef
  • Surrogate markers and predictors of endogenous insulin secretion in children and adolescents with type 1 diabetes
    Jin-Na Yuan, Jian-Wei Zhang, Wayne S. Cutfield, Guan-Ping Dong, You-Jun Jiang, Wei Wu, Ke Huang, Xiao-Chun Chen, Yan Zheng, Bi-Hong Liu, José G. B. Derraik, Jun-Fen Fu
    World Journal of Pediatrics.2021; 17(1): 99.     CrossRef
  • Nano-based drug delivery systems used as vehicles to enhance polyphenols therapeutic effect for diabetes mellitus treatment
    Sónia Rocha, Mariana Lucas, Daniela Ribeiro, M. Luísa Corvo, Eduarda Fernandes, Marisa Freitas
    Pharmacological Research.2021; 169: 105604.     CrossRef
  • Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
    Ghasem Yadegarfar, Mark Livingston, Gabriela Cortes, Ramadan Alshames, Kate Leivesley, Ann Metters, Linda Horne, Tom Steele, Adrian H. Heald
    Cardiovascular Endocrinology & Metabolism.2021; 10(2): 132.     CrossRef
  • Association between reduced serum levels of magnesium and the presence of poor glycemic control and complications in type 1 diabetes mellitus: A systematic review and meta-analysis
    Ana Kelen Rodrigues, Ana Elisa Melo, Caroline Pereira Domingueti
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(2): 127.     CrossRef
  • Insulin-Producing Cell Transplantation Platform for Veterinary Practice
    Suryo Kuncorojakti, Sayamon Srisuwatanasagul, Krishaporn Kradangnga, Chenphop Sawangmake
    Frontiers in Veterinary Science.2020;[Epub]     CrossRef
  • Type 1 Diabetes Home Care Project and Educational Consultation
    Eun Chong Shin
    The Journal of Korean Diabetes.2020; 21(2): 88.     CrossRef
  • Decision-Making in Artificial Intelligence: Is It Always Correct?
    Hun-Sung Kim
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UK
    Ghasem Yadegarfar, Simon G. Anderson, Zohaib Khawaja, Gabriela Cortes, Kathryn Leivesley, Ann Metters, Linda Horne, Tom Steele, Adrian H. Heald
    Cardiovascular Endocrinology & Metabolism.2020; 9(4): 171.     CrossRef
  • Dose-dependent effects of necrostatin-1 supplementation to tissue culture media of young porcine islets
    Hien Lau, Nicole Corrales, Samuel Rodriguez, Colleen Luong, Mohammadreza Mohammadi, Veria Khosrawipour, Shiri Li, Michael Alexander, Paul de Vos, Jonathan R. T. Lakey, Zoltán Rakonczay
    PLOS ONE.2020; 15(12): e0243506.     CrossRef
  • New Insulin Pumps and Open Source Artificial Pancreas System in Korea
    Jae Hyeon Kim
    The Journal of Korean Diabetes.2020; 21(4): 197.     CrossRef
  • Perspective and general approach of diabetes in palliative care
    Díaz Rodríguez Juan Javier
    Hospice and Palliative Medicine International Journal.2018;[Epub]     CrossRef
  • The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations
    Fatemeh Delkhosh-Kasmaie, Amir Abbas Farshid, Esmaeal Tamaddonfard, Mehdi Imani
    Biomedicine & Pharmacotherapy.2018; 107: 203.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP